Literature DB >> 24900431

Synthesis and antiproliferative activities of ottelione a analogues.

Tsai-Yuan Chang1, Yun-Peng Tu1, Win-Yin Wei2, Hsiang Yu Chen2, Chih-Shang Chen3, Ying-Shuan E Lee2, Jiann-Jyh Huang4, Chin-Kang Sha1.   

Abstract

Through the syntheses of its C-1 desvinyl, C-7 methylene, C-7 exocyclic ethylidene, and various C-3 phenylmethyl analogues, the structure-activity relationship of antimitotic ottelione A (4) against tubulin and various cancer cells was established. The results indicated that compound 4 was a colchicine-competitive inhibitor and that the C-1 vinyl group is unnecessary for its potency, whereas the C-7 exocyclic double bond is essential, possibly because of its irreversible interaction with tubulin. Further optimization of the substituents on the phenylmethyl group at the C-3 position generated compound 10g with a 3'-fluoro-4'-methoxyphenylmethyl substituent, which was 6-38-fold more active against MCF-7, NCI-H460, and COLO205 cancer cells relative to 4. Results from in vitro tubulin polymerization assay confirmed the potency of compounds 4, 10g, and 11a.

Entities:  

Keywords:  anticancer; antimitotic; microtubule; ottelione A; tubulin

Year:  2012        PMID: 24900431      PMCID: PMC4025792          DOI: 10.1021/ml300283f

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

Review 1.  Irreversible inhibitors of serine, cysteine, and threonine proteases.

Authors:  James C Powers; Juliana L Asgian; Ozlem Dogan Ekici; Karen Ellis James
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  Total synthesis and absolute configuration of otteliones A and B, novel and potent antitumor agents from a freshwater plant.

Authors:  Hiroshi Araki; Munenori Inoue; Tadashi Katoh
Journal:  Org Lett       Date:  2003-10-16       Impact factor: 6.005

Review 3.  Microtubules as a target for anticancer drugs.

Authors:  Mary Ann Jordan; Leslie Wilson
Journal:  Nat Rev Cancer       Date:  2004-04       Impact factor: 60.716

4.  Synthesis of the otteliones A and B: use of a cyclopropyl group as both a steric shield and a vinyl equivalent.

Authors:  Derrick L J Clive; Dazhan Liu
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors.

Authors:  Laurens V Beerepoot; Sandra A Radema; Els O Witteveen; Tawnie Thomas; Catherine Wheeler; Sanford Kempin; Emile E Voest
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

6.  Enantioselective total synthesis of otteliones A and B.

Authors:  Cheng-Hui Chen; Yu-Kai Chen; Chin-Kang Sha
Journal:  Org Lett       Date:  2010-04-02       Impact factor: 6.005

7.  A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors.

Authors:  Elizabeth Fox; John M Maris; Brigitte C Widemann; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Molly E Fouts; Diane Medina; Susan L Cohn; Andrew Krivoshik; Anne E Hagey; Peter C Adamson; Frank M Balis
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

8.  A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.

Authors:  Ann M Mauer; Ezra E W Cohen; Patrick C Ma; Mark F Kozloff; Lee Schwartzberg; Andrew I Coates; Jiang Qian; Anne E Hagey; Gary B Gordon
Journal:  J Thorac Oncol       Date:  2008-06       Impact factor: 15.609

9.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

Authors:  B Shan; J C Medina; E Santha; W P Frankmoelle; T C Chou; R M Learned; M R Narbut; D Stott; P Wu; J C Jaen; T Rosen; P B Timmermans; H Beckmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 10.  Recent development and SAR analysis of colchicine binding site inhibitors.

Authors:  Jing Chen; Tao Liu; Xiaowu Dong; Yongzhou Hu
Journal:  Mini Rev Med Chem       Date:  2009-09       Impact factor: 3.862

View more
  2 in total

1.  New diarylheptanoids and a hydroxylated ottelione from Ottelia alismoides.

Authors:  Thomas R Hoye; Seif-Eldin N Ayyad; Hollie J Beckord; Susan G Brown
Journal:  Nat Prod Commun       Date:  2013-03       Impact factor: 0.986

2.  Therapeutic effects of the euglenoid ichthyotoxin, euglenophycin, in colon cancer.

Authors:  April B Cabang; Keya De Mukhopadhyay; Sarah Meyers; Jay Morris; Paul V Zimba; Michael J Wargovich
Journal:  Oncotarget       Date:  2017-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.